Hillhouse Capital Group

CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Retrieved on: 
Friday, October 8, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Vascular endothelial growth factor A, Therapy, Compass, Hillhouse Capital Group, Doctor of Philosophy, OTC, Safety, Cancer, Neurodegeneration, Population, SEC, AACR, ECOG, Stomach, ABL, Rest, Bevacizumab, ORR, Cholangiocarcinoma, Conference, KOSDAQ, Samsung Medical Center, Lists of diseases, Eli Lilly and Company, Abstract, Clinical trial, Multimedia, Partial, Immune system, Hypertension, CNS, Colorectal cancer, Tumor microenvironment, DLL4, DCR, Neoplasm, RECIST, Traffic barrier, BBB, CMO, Industry, Pulmonary hypertension, CDH, CEO, Patient, Pharmaceutical industry, Vaccine, CTX-009, Compass Therapeutics, ABL Bio, Elpiscience BioPharma, CTX-009, COMPASS THERAPEUTICS, ABL BIO, ELPISCIENCE BIOPHARMA

Among those, 7 patients reported Grade 3 hypertension and the rest had Grade 1 or Grade 2 (16%).

Key Points: 
  • Among those, 7 patients reported Grade 3 hypertension and the rest had Grade 1 or Grade 2 (16%).
  • Only 4 mild cases of pulmonary hypertension were reported that were all reversible, and CTX-009 demonstrated significant clinical activity as a stand-alone therapy.
  • This is a significant clinical result because current approved anti-angiogenic drugs have little efficacy as a monotherapy.
  • Elpiscience endeavors to advance at least one world-class molecule into the clinic each year, providing clinical benefits to cancer patients worldwide.

Kava Labs Announces Partnership With CertiK to Secure The Kava Ecosystem

Retrieved on: 
Wednesday, October 6, 2021
Mobile, Wireless, Technology, Finance, Security, Other Technology, Professional Services, Software, Networks, Internet, Data Management, Ignition, Decentralized finance, Leaderboard, Partnership, Kava, Environment, Columbia University, Risk, Technology, Blockchain, Coatue Management, Hillhouse Capital Group, Architecture, Ecosystem, Tiger Global Management, Yale University, Cryptocurrency, Kava Labs, CertiK, KAVA LABS, CERTIK

CertiK, a leader in blockchain security, has been selected by Kava Labs to receive a portion of the Kava Ignition Fund to provide enhanced security for the Kava Ecosystem.

Key Points: 
  • CertiK, a leader in blockchain security, has been selected by Kava Labs to receive a portion of the Kava Ignition Fund to provide enhanced security for the Kava Ecosystem.
  • As a leader in blockchain security, CertiK is the perfect early partner for the Kava Ecosystem.
  • Its only natural that wed onboard CertiK to secure the Kava Ecosystem and protect its users.
  • With the support of CertiK, the Kava Ecosystem can guarantee both its users and future partners the most secure experience in DeFi.

Global Consumer Electronics & Home Appliances Market (2021 to 2026) - by Type, Distribution Channel and Geography

Retrieved on: 
Friday, October 1, 2021
Philips, Porter's five forces analysis, Observation, Hitachi, Geography, Toshiba, Consumer electronics, CAGR, Market share, COVID-19, Industry, Growth, Electronics, Impact, India, Ansoff Matrix, Hillhouse Capital Group, Major appliance, Competitive analysis, IRobot, Investment, Arçelik, Retail

The Global Consumer Electronics & Home Appliances Market is projected to grow at a CAGR of 8.3% from 2021 to 2026.

Key Points: 
  • The Global Consumer Electronics & Home Appliances Market is projected to grow at a CAGR of 8.3% from 2021 to 2026.
  • The consumer electronics and home appliances market is highly driven by customers' preference for innovative and smart products.
  • The major challenge for the global consumer electronics and home appliances market is first copies and duplicated products.
  • This factor is expected to hinder the growth of the global consumer electronics and home appliances market.

Insights on the Consumer Electronics & Home Appliances Global Market to 2026 - Competitive Analysis and the Impact of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 1, 2021
Technology, Retail, Home Goods, Consumer Electronics, Philips, Porter's five forces analysis, Observation, Toshiba, COVID-19, Growth, Electronics, India, Ansoff Matrix, Hillhouse Capital Group, Major appliance, Investment, Industry, Retail

The consumer electronics and home appliances market is highly driven by customers' preference for innovative and smart products.

Key Points: 
  • The consumer electronics and home appliances market is highly driven by customers' preference for innovative and smart products.
  • The major challenge for the global consumer electronics and home appliances market is first copies and duplicated products.
  • This factor is expected to hinder the growth of the global consumer electronics and home appliances market.
  • The report offers a comprehensive evaluation of the Global Consumer Electronics & Home Appliances Market.

Venture Global LNG and PGNiG Finalize Expansion of LNG Partnership

Retrieved on: 
Thursday, September 2, 2021
Electricity, Hydrogen, Capital Group Companies, Hillhouse Capital Group, Natural gas, PGNiG, FOB, Warsaw Stock Exchange, Multimedia, Carbon, MTPA, Partnership, Carbon footprint

WARSAW, Poland, Sept. 2, 2021 /PRNewswire/ -- Today, Venture Global LNG and PGNiG (Polish Oil and Gas Company) finalized an agreement under which PGNiG will purchase an additional 2 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global for 20 years. Cargoes will be supplied from Venture Global's Calcasieu Pass LNG and Plaquemines LNG export facilities. The documents were signed during a ceremony at the Warsaw Stock Exchange. 

Key Points: 
  • WARSAW, Poland, Sept. 2, 2021 /PRNewswire/ -- Today, Venture Global LNG and PGNiG (Polish Oil and Gas Company) finalized an agreement under which PGNiG will purchase an additional 2 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global for 20 years.
  • "Venture Global is proud to expand our existing partnership with PGNiG to provide a clean and reliable supply of American LNG to Poland.Since 2018, our two companies have significantly increased our cooperation, nearly tripling the volume of LNG Venture Global will export to PGNiG.
  • This brings the total volume of LNG PGNiG has committed to purchase from Venture Global facilities to 5.5 MTPA, for 20 yearson a free-on-board basis (FOB).
  • Venture Global is a long-term, low-cost provider of U.S. LNG to be sourced from resource rich North American natural gas basins.

Venture Global LNG and PGNiG Finalize Expansion of LNG Partnership

Retrieved on: 
Thursday, September 2, 2021
Electricity, Hydrogen, Capital Group Companies, Hillhouse Capital Group, Natural gas, PGNiG, FOB, Warsaw Stock Exchange, Carbon, MTPA, Partnership, Carbon footprint

WARSAW, Poland, Sept. 2, 2021 /PRNewswire/ -- Today, Venture Global LNG and PGNiG (Polish Oil and Gas Company) finalized an agreement under which PGNiG will purchase an additional 2 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global for 20 years. Cargoes will be supplied from Venture Global's Calcasieu Pass LNG and Plaquemines LNG export facilities. The documents were signed during a ceremony at the Warsaw Stock Exchange. 

Key Points: 
  • WARSAW, Poland, Sept. 2, 2021 /PRNewswire/ -- Today, Venture Global LNG and PGNiG (Polish Oil and Gas Company) finalized an agreement under which PGNiG will purchase an additional 2 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global for 20 years.
  • "Venture Global is proud to expand our existing partnership with PGNiG to provide a clean and reliable supply of American LNG to Poland.Since 2018, our two companies have significantly increased our cooperation, nearly tripling the volume of LNG Venture Global will export to PGNiG.
  • This brings the total volume of LNG PGNiG has committed to purchase from Venture Global facilities to 5.5 MTPA, for 20 yearson a free-on-board basis (FOB).
  • Venture Global is a long-term, low-cost provider of U.S. LNG to be sourced from resource rich North American natural gas basins.

SGX, Trumid and Hillhouse Capital form joint venture to launch new Asian bond trading platform

Retrieved on: 
Monday, February 8, 2021
Economy, Finance, Money, Hillhouse Capital Group, Hillhouse, Singapore Exchange, Bond, Investor, Financial market

XinTru will launch and operate Trumid XT, an electronic bond trading platform powered by advanced technology and rich analytics.

Key Points: 
  • XinTru will launch and operate Trumid XT, an electronic bond trading platform powered by advanced technology and rich analytics.
  • Trumid XT will enhance international access to Asian bond markets, while also facilitating Asian investor participation in US and global emerging market credit.
  • Trumid has established a leadership position in electronic bond trading innovation since the company's launch in 2015.
  • Strategic Partnership To Elevate Bond Trading in Asia:
    SGX first invested in Trumid back in 2018 and subsequently joined Hillhouse Capital in another round of investment in 2019 when Hillhouse Capital took a minority stake in Trumid.

InnoCare Brings On Hillhouse as Strategic Investor, Vivo Capital Increases Holdings

Retrieved on: 
Thursday, February 4, 2021
Research, Finance, Clinical trials, Professional services, Biotechnology, Health, Pharmaceutical, Science, Oncology, Finance, Money, Investment, Hillhouse Capital Group, Hillhouse, Vivo, Hong Kong Exchanges and Clearing, Investor, Hillhouse Capital, Vivo Capital, InnoCare

InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today two subscription agreements with Gaoling and YHG, a company of Hillhouse Capital Group, and Vivo Opportunity Fund, L.P, a company of Vivo Capital VIII, LLC.

Key Points: 
  • InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today two subscription agreements with Gaoling and YHG, a company of Hillhouse Capital Group, and Vivo Opportunity Fund, L.P, a company of Vivo Capital VIII, LLC.
  • Hillhouse Capital adheres to the philosophy of value investing, and Vivo Capital focuses on investing in high-quality companies in the fields of life science and healthcare.
  • Based on the long-term investments, Hillhouse Capital has attached great importance to the biotech sector and values company's long-term growth capabilities.
  • Dr. Jasmine Cui, the co-founder, Chairwoman and CEO of InnoCare said, I am very pleased that Hillhouse Capital has joined as a strategic investor.

Enfusion Receives $150M Investment from ICONIQ Growth as it Continues to Redefine Investment Management Technology Solutions

Retrieved on: 
Monday, January 11, 2021
Hillhouse Capital Group, Investment management, Hillhouse, Investment, Finance

CHICAGO, NEW YORK, LONDONandHONG KONG, Jan. 11, 2021 /PRNewswire/ -- Enfusion, a global leader in investment management technology solutions and services, announced that it has received a $150 million minority investment from ICONIQ Growth.

Key Points: 
  • CHICAGO, NEW YORK, LONDONandHONG KONG, Jan. 11, 2021 /PRNewswire/ -- Enfusion, a global leader in investment management technology solutions and services, announced that it has received a $150 million minority investment from ICONIQ Growth.
  • ICONIQ Growth joins FTV Capital and Hillhouse Capital as institutional investors in the company.
  • "We are delighted to support Enfusion in its efforts to radically disrupt the investment management solution space," said Roy Luo, Principal at ICONIQ Growth.
  • Our investment in Enfusion is representative of our commitment to invest in best-in-class, long-view technology businesses and we are excited to collaborate with their experienced management team during their next phase of strategic growth."

Overland Pharmaceuticals Debuts as Premier Biopharmaceutical Company to Bring Innovative Medicines to Asia and Worldwide

Retrieved on: 
Wednesday, December 9, 2020
Biotechnology, Pharmaceutical, Health, Hillhouse Capital Group, Hillhouse, Overland, Pharmaceutical industry in China, Health, Pharmaceutical industry in India, Investment, Overland Pharmaceuticals, Hillhouse Capital

Backed by Hillhouse Capital (Hillhouse), Overland Pharmaceuticals (Overland) today announced its official launch with a mission to bring innovative medicines to underserved patients in Asia and around the world.

Key Points: 
  • Backed by Hillhouse Capital (Hillhouse), Overland Pharmaceuticals (Overland) today announced its official launch with a mission to bring innovative medicines to underserved patients in Asia and around the world.
  • The global investment firm Hillhouse is providing Overland with support to build a fully integrated biopharmaceutical company through collaborations in select disease areas.
  • The company will operate in three international offices in Shanghai and Beijing, China and Boston, Massachusetts.
  • Overland Pharmaceuticals is building a fully integrated biopharma company with a mission to bring innovative medicines to underserved patients in Asia and around the world.